Medirom Healthcare Technologies Inc. MRM
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Revenue compounded at +16.3% a year over the five years to FY2024 — but profit grew faster: net income at +53.7%.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each JPY of equity produced 26 cents of profit this year.
The 6-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue JPY B | 8.3 | 6.8 | 7.0 | 5.4 | 3.3 | 3.9 |
| Operating income JPY B | −0.0 | −0.4 | 0.1 | −0.5 | −0.7 | 0.0 |
| EBITDA JPY B | 0.3 | −0.1 | 0.3 | −0.3 | −0.7 | 0.1 |
| Income tax JPY B | −0.1 | −0.1 | 0.0 | 0.6 | −0.1 | 0.0 |
| Net income JPY B | 0.1 | 0.1 | 0.1 | −1.0 | −0.5 | 0.0 |
| Free cash flow JPY B | −1.4 | −0.8 | −0.8 | −0.7 | −0.4 | 0.0 |
| EPS, diluted JPY | 28.52 | 22.34 | 27.23 | −203.13 | −133.97 | 4.06 |
| Dividend / sh JPY | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — |
| ROE % | 26.0 | — | — | — | −98.8 | — |
| Shares out B | 0.01 | 0.00 | 0.00 | 0.00 | ◌ | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 6 of the 6 fiscal years we could check. 24 checks were skipped: the balance sheet is not tagged before 2019. 15 checks were skipped: cost of revenue is not tagged before 2022. 12 checks were skipped: EPS is not tagged before 2019.